Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Genome-wide mapping of HIF-2 binding in 786-O clear cell renal carcinoma cells


ABSTRACT: Kidney cancer accounts for more than 100,000 deaths per year world-wide. More than 80% are clear cell tumors (ccRCCs) and the majority are associated with loss of function of the von Hippel Lindau (pVHL) tumor suppressor resulting in upregulation of HIF-{alpha} subunits, and activation of HIF-dependent transcriptional pathways. Recent GWAS studies have discovered RCC-susceptibility loci both within EPAS1 (HIF-2{alpha}) and in an intergenic region of unknown function on 11q13.3. As part of an ongoing study to define the direct transcriptional targets of HIF-2 in renal cancer, we undertook a genome-wide analysis of HIF-2-binding sites in pVHL-defective 786-O cells (that lack functional HIF-1{alpha} due to a truncated transcript) using chromatin immunoprecipitation with antibodies directed against HIF-2{alpha} and its dimerization partner HIF-1{beta}, coupled to high-throughput sequencing (ChIP-seq). Amongst approximately 600 pangenomic HIF-2{beta} ChIP signals, we observed strong binding (ranked 12th by peak height) almost precisely coinciding with the RCC predisposition SNP rs7105934 on 11q13.3. We report binding of HIF-2{alpha} and HIF-1{beta} in 786-O clear cell renal carcinoma cells. 3 samples examined, HIF-2{alpha}, HIF-1{beta} and pre-immune control ChIP.

ORGANISM(S): Homo sapiens

SUBMITTER: David Mole 

PROVIDER: E-GEOD-34871 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression.

Schödel Johannes J   Bardella Chiara C   Sciesielski Lina K LK   Brown Jill M JM   Pugh Chris W CW   Buckle Veronica V   Tomlinson Ian P IP   Ratcliffe Peter J PJ   Mole David R DR  

Nature genetics 20120311 4


Although genome-wide association studies (GWAS) have identified the existence of numerous population-based cancer susceptibility loci, mechanistic insights remain limited, particularly for intergenic polymorphisms. Here, we show that polymorphism at a remote intergenic region on chromosome 11q13.3, recently identified as a susceptibility locus for renal cell carcinoma, modulates the binding and function of hypoxia-inducible factor (HIF) at a previously unrecognized transcriptional enhancer of CC  ...[more]

Similar Datasets

2012-04-03 | E-GEOD-34037 | biostudies-arrayexpress
2012-04-03 | E-GEOD-34036 | biostudies-arrayexpress
2012-04-03 | E-GEOD-33994 | biostudies-arrayexpress
2010-07-10 | E-GEOD-20867 | biostudies-arrayexpress
2010-03-08 | E-GEOD-20673 | biostudies-arrayexpress
2010-01-27 | E-GEOD-19365 | biostudies-arrayexpress
2010-12-31 | E-GEOD-24973 | biostudies-arrayexpress
2010-09-08 | E-GEOD-21665 | biostudies-arrayexpress
2011-04-05 | E-GEOD-28352 | biostudies-arrayexpress
2016-03-01 | E-GEOD-53357 | biostudies-arrayexpress